I have an active interest in all aspects of Benign Hematology, particularly in congenital bleeding disorders and acquired diseases of hemostasis, such as thrombotic microangiopathies and immune-mediated cytopenias. These conditions are rare and often occur in under-represented populations, which makes their research and development even more necessary. By offering a wide array of clinical trials for these disease states, we can move care forward and offer improved therapies
For Referring Providers:
My research interests run the entire gamut of Benign Hematology, particularly as many of these conditions are uncommon or rare, and often enough, under-represented. By bringing clinical trials to these patients, this is a way to improve care for our patients.